Skip to main content
Log in

Agranulocytosis during treatment with clozapine

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Within six months of the introduction of the new antipsychotic drug clozapine in Finland, 17 cases of neutropenia or agranulocytosis were recorded amongst about 3000 patients treated. Agranulocytosis was fatal in eight patients, and in addition, two patients developed thrombocytopenia, and one patient leukaemia. As additional cases might well have been overlooked as banal infections, the risk of developing agranulocytosis during clozapine treatment was at least 0.5%. Impaired elimination of the drug or increased susceptibility of granulocyte precursors to clozapine, possibly due to some inherited characteristic, might explain the high incidence of complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gross, H., Lagner, E.: Das Wirkungsprofil eines chemisch neuartigen Breitbandneuroleptikums der Benzodiazepingruppe. Wien. med. Wschr.116, 814–818 (1966)

    Google Scholar 

  2. Angst, J., Jaenicke, U., Padrutt, A., Scharfetter, Ch.: Ergebnisse eines Doppelblindversuches von HF 1854 im Vergleich zu Levomepromazin. Pharmakopsychiat.4, 192–200 (1971)

    Google Scholar 

  3. Gross, H., Lagner, E.: Das Neuroleptikum 100–129/HF-1854 (Clozapin) in der Psychiatrie. Pharmakopsychiat.4, 220–226 (1970)

    Google Scholar 

  4. Griffith, R. W., Saameth, K.: Clozapine and agranulocytosis. Lancet1975 II, 657

    Google Scholar 

  5. Niskanen, P., Achté, K. A., Jaskari, M., Karesoja, M., Melsted, B., Nilsson, L., Routavaara, M., Tamminen, T., Tienari, P., Vogel, G.: Result of a comparative double-blind study with clozapine and chlorpromazine in the treatment of schizophrenic patients. Psychiat. Fennica1, 307–312 (1974)

    Google Scholar 

  6. Idänpään-Heikkilä, J., Alhava, E., Olkinuora, M., Palva, J.: Clozapine and agranulocytosis. Lancet1975 II, 611.

    Google Scholar 

  7. Pisciotta, A. V.: Effects of phenothiazines on leukocytes. In: Drugs and hematologic reactions (ed. N. V. Dimitrov, J. H. Nodie) p. 233. New York: Grune and Stratton 1974

    Google Scholar 

  8. Palva, L. P., Mustala, O. O.: Drug-induced agranulocytosis with special reference to aminophenazone. Acta med. scand.187, 109–112 (1970)

    Google Scholar 

  9. Nieweg, H. O.: Drug induced diseases as seen by a haematologist. In: Drug-induced diseases (ed. L. Meyler, H. M. Peck) p. 323. Amsterdam: Excerpta Medica 1972

    Google Scholar 

  10. Blum, A., Mauruschat, W.: Über Temperaturanstiege unter der Therapie mit Psychopharmaka. Jugoslav. Symposium über Psychopharmakologie, Zagreb 1969

  11. Pisciotta, A. V.: Studies on agranulocytosis. VII. Limited proliferative potential of chlorpromazine sensitive patients. J. Lab. clin. Med.65, 240–247 (1965)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

By the Working Group of the Finnish National Board of Health on the side-effects of clozapine

Rights and permissions

Reprints and permissions

About this article

Cite this article

Idänpään-Heikkilä, J., Alhava, E., Olkinuora, M. et al. Agranulocytosis during treatment with clozapine. Eur J Clin Pharmacol 11, 193–198 (1977). https://doi.org/10.1007/BF00606409

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00606409

Key words

Navigation